<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) are a group of clonal <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">haematological disorders</z:e> characterized by cytopenia(s), reduced differentiation-capacity of myeloid cells, and impaired leukocyte function </plain></SENT>
<SENT sid="1" pm="."><plain>However, little is known so far about basophil granulocytes in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>DESIGN: We have compared the numbers, phenotype and function of basophils in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients with those in healthy subjects </plain></SENT>
<SENT sid="3" pm="."><plain>A total numer of 23 patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> (refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo>, n = 8; refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with ringsideroblasts, n = 7; refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with excess of blasts/refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with excess of blasts in transformation, n = 8) and 20 healthy donors were included </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The numbers of blood basophils in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients (34.6 +/- 62.9 microL-1) was lower compared to healthy controls (58.6 +/- 64.9 microL-1) </plain></SENT>
<SENT sid="5" pm="."><plain>Correspondingly, whole blood <z:chebi fb="11" ids="18295">histamine</z:chebi> levels were lower in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> 34.1 +/- 29.1 ng mL-1 vs. <z:mpath ids='MPATH_458'>normal</z:mpath> donors 72.0 +/- 36.9 ng mL-1) </plain></SENT>
<SENT sid="6" pm="."><plain>Like "<z:mpath ids='MPATH_458'>normal</z:mpath>" basophils, basophils in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> expressed interleukin-3 receptor alpha (CD123), E-NPP3 (CD203c), CR1 (CD35), CR3 (CD11b), CR4 (CD11c), membrane co-factor protein (CD46), decay-accelerating factor (CD55) and membrane attack complex inhibitory factor (CD59), as well as receptors for C3a, C5a (CD88), and IgE </plain></SENT>
<SENT sid="7" pm="."><plain>Recombinant human (rh) C5a and anti-IgE induced significant release of <z:chebi fb="11" ids="18295">histamine</z:chebi> from basophils in both groups of donors without significant differences between <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and healthy controls </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: The absolute numbers of basophils in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients are lower than in <z:mpath ids='MPATH_458'>normal</z:mpath> donors </plain></SENT>
<SENT sid="9" pm="."><plain>However, basophils in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> do not differ from their "<z:mpath ids='MPATH_458'>normal</z:mpath> counterparts" in terms of complement receptor expression, IgE-receptor expression, or functional responses to respective ligands </plain></SENT>
</text></document>